GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » 3B BlackBio Dx Ltd (BOM:532067) » Definitions » EV-to-EBIT

3B BlackBio Dx (BOM:532067) EV-to-EBIT : 16.05 (As of May. 20, 2024)


View and export this data going back to 1996. Start your Free Trial

What is 3B BlackBio Dx EV-to-EBIT?

EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, 3B BlackBio Dx's Enterprise Value is ₹6,274.5 Mil. 3B BlackBio Dx's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 was ₹390.9 Mil. Therefore, 3B BlackBio Dx's EV-to-EBIT for today is 16.05.

The historical rank and industry rank for 3B BlackBio Dx's EV-to-EBIT or its related term are showing as below:

BOM:532067' s EV-to-EBIT Range Over the Past 10 Years
Min: 1.12   Med: 8.54   Max: 21.28
Current: 16.05

During the past 13 years, the highest EV-to-EBIT of 3B BlackBio Dx was 21.28. The lowest was 1.12. And the median was 8.54.

BOM:532067's EV-to-EBIT is ranked worse than
59.21% of 429 companies
in the Biotechnology industry
Industry Median: 9.96 vs BOM:532067: 16.05

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %. 3B BlackBio Dx's Enterprise Value for the quarter that ended in Dec. 2023 was ₹6,776.4 Mil. 3B BlackBio Dx's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 was ₹390.9 Mil. 3B BlackBio Dx's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Dec. 2023 was 5.77%.


3B BlackBio Dx EV-to-EBIT Historical Data

The historical data trend for 3B BlackBio Dx's EV-to-EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

3B BlackBio Dx EV-to-EBIT Chart

3B BlackBio Dx Annual Data
Trend Mar14 Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23
EV-to-EBIT
Get a 7-Day Free Trial Premium Member Only Premium Member Only 6.95 4.90 1.30 5.78 7.90

3B BlackBio Dx Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
EV-to-EBIT Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 10.07 7.90 8.24 14.11 17.33

Competitive Comparison of 3B BlackBio Dx's EV-to-EBIT

For the Biotechnology subindustry, 3B BlackBio Dx's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


3B BlackBio Dx's EV-to-EBIT Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, 3B BlackBio Dx's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where 3B BlackBio Dx's EV-to-EBIT falls into.



3B BlackBio Dx EV-to-EBIT Calculation

3B BlackBio Dx's EV-to-EBIT for today is calculated as:

EV-to-EBIT=Enterprise Value (Today)/EBIT (TTM)
=6274.469/390.941
=16.05

3B BlackBio Dx's current Enterprise Value is ₹6,274.5 Mil.
3B BlackBio Dx's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹390.9 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


3B BlackBio Dx  (BOM:532067) EV-to-EBIT Explanation

This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %.

3B BlackBio Dx's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Dec. 2023 is calculated as:

Earnings Yield (Joel Greenblatt) % (Q: Dec. 2023 ) =EBIT / Enterprise Value (Q: Dec. 2023 )
=390.941/6776.4470985
=5.77 %

3B BlackBio Dx's Enterprise Value for the quarter that ended in Dec. 2023 was ₹6,776.4 Mil.
3B BlackBio Dx's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹390.9 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


3B BlackBio Dx EV-to-EBIT Related Terms

Thank you for viewing the detailed overview of 3B BlackBio Dx's EV-to-EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.


3B BlackBio Dx (BOM:532067) Business Description

Traded in Other Exchanges
N/A
Address
7-C, Industrial Area, Govindpura, Bhopal, MP, IND, 462023
3B BlackBio Dx Ltd is one of the leading Indian companies in the field of PCR-based Molecular Diagnostic Kits. The Company is ISO 13485:2016 certified, GMP-compliant biotech R&D organization, as an Indo-Spanish JV company and engaged in the design, development, manufacturing and commercialization of PCR based Molecular Diagnostic kits, PCR Enzymes & PCR Reagents.

3B BlackBio Dx (BOM:532067) Headlines

No Headlines